Navigation Links
Microdosing: Updating its role in developing new medicines
Date:1/23/2013

One of yesterday's most promising new tools for speeding the development of new medicines "microdosing" has found niches in that process today, and they include uses unanticipated a decade ago. That topic, an update on microdosing, is the cover story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.

C&EN Senior Editor Celia Henry Arnaud explains that microdosing offered promise for helping pharmaceutical companies identify potential failures earlier, before starting full-fledged clinical trials of a potential new drug. It involves giving subtherapeutic doses 1 percent of the full dose to human volunteers after minimal animal testing. Scientists then would use the results to determine whether to move ahead with expensive safety testing in traditional Phase 1 clinical trials. Microdosing promised to become a standard part of drug development, adding a new so-called Phase 0 to that process.

The article points out that occasional Phase 0 clinical trials do, indeed, take place. But microdosing most often is used in "absolute bioavailability studies," done in parallel with standard clinical trials to determine how much of the drug actually reaches its target tissue to treat the disease. Other uses of microdosing may emerge in the years ahead, the article notes.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

0

GOOD

Page: 1

Related biology news :

1. First special edition updating progress on efforts to map human proteins
2. Developing microbial cell factories by employing synthetic small regulatory RNAs
3. Developing second skin military fabric to repel chemical and biological agents
4. Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries
5. Watching the developing brain, scientists glean clues on neurological disorder
6. Cilia guide neuronal migration in developing brain
7. First-ever 3-D stress map of developing embryonic heart sheds light on why defects form
8. The role of stem cells in developing new drugs
9. Sam Houston state developing lab test for bath salts
10. Purple corn compound may aid in developing future treatments for Type 2 diabetes, kidney disease
11. Risk of developing diabetes higher in neighborhoods that arent walk-friendly: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... are threatened with extinction as a result of rising human ... Ohio State University in the US. Their work is also ... human population will continue to pose a threat to other ... a threshold above which population growth would cease to have ... Springer,s journal, Human Ecology . , It has long ...
(Date:6/19/2013)... 2013 A decade-long JDRF-funded study led by ... Mnchen, Germany, is providing a deeper understanding of ... developing type 1 diabetes (T1D), highlighting the importance ... disease. The study, "Seroconversion to Multiple Islet Autoantibodies ... was published today in The Journal of ...
(Date:6/19/2013)... study offers further proof that the divergence of humans ... ago was profoundly influenced by mutations to DNA sequences ... , The study, published June 9 in Nature ... regulation of genes must play an important role in ... chimps in the proteins produced by genes. Indeed, human ...
Breaking Biology News(10 mins):Are we pushing animals over the edge? 2New data on islet autoantibodies in young children defines early type 1 diabetes development 2New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3
... of the central nervous system (CNS) in animal evolution ... evolved from the same ancestor, but their CNSs are ... their lineages had split during evolution. Researchers from the ... that the vertebrate nervous system is probably much older ...
... group of organisms that has never had sex in ... to evolve into distinct species, says new research published ... necessary for organisms to diversify and provides scientists with ... place. , The research, published in PLoS Biology, ...
... cancer is a metaphorical example of the perfect invasion by ... on a deserted island in the Galapagos Archipelago, the first ... mutations through many generations to establish itself as an invader ... there, like any newly stabilized species in different ecological niches, ...
Cached Biology News:The origin of the brain lies in a worm 2No sex for 40 million years? No problem 2New bird, bat species revealed by extensive DNA barcode studies 2
(Date:6/18/2013)... June 18, 2013 (PRWEB) June 18, 2013 ... and attendance system in North America, has introduced ... employee data and payroll records between ExakTime’s software ... automates ExakTime software setup and keeps employee ... employee data from a business’ current payroll software, ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Nasseo, Inc. ... Innovation Challenge Winner out of hundreds of applicants by ... spring Arizona Innovation Challenge . The Arizona Innovation ... for a technology commercialization challenge, granting a financial award ... promising technology ventures. Nasseo’s state of the art dental ...
(Date:6/18/2013)... ALBANY, N.Y. , June 18, 2013 /PRNewswire/ ... that its Burlington, Mass. , ... U.S. Drug Enforcement Administration (DEA) registration to handle ... represents the DEA,s acknowledgement of Burlington,s ... inventory control and documentation. (Logo: ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
... in Total Proceeds Retire Safeguard Mezzanine Debt Facility; Support ... Clarient , Inc. (Nasdaq: CLRT ), ... for pathologists, oncologists and the pharmaceutical industry, announced today ... private placement of convertible preferred stock with ...
... -- China Dasheng,Biotechnology Company ("China Dasheng" or "the Company") ... organic bacteria based additives,for crops and livestock feeds in ... of fiscal year 2009, which ended March 31, 2009. ... (all figures in US$) included:, -- ...
... -- Rodobo International,Inc. (OTC Bulletin Board: RDBO), one of ... for the second quarter and,first six months ended March ... financial highlights include: , Revenue ... $6.3 million, an,increase of 19% compared to Q2 2008. ...
Cached Biology Technology:Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 2Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 3Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 4Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 5Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 6China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 2China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 3China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 4China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 5China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 6China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 7China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 8Rodobo International, Inc. Reports Q2 and First Half of 2009 2Rodobo International, Inc. Reports Q2 and First Half of 2009 3Rodobo International, Inc. Reports Q2 and First Half of 2009 4Rodobo International, Inc. Reports Q2 and First Half of 2009 5Rodobo International, Inc. Reports Q2 and First Half of 2009 6Rodobo International, Inc. Reports Q2 and First Half of 2009 7Rodobo International, Inc. Reports Q2 and First Half of 2009 8
The HQ505, 20 OptiGreen filter for the Molecular Imager FX is a band pass filter used for detection of Cy2 and FITC with 532 nm excitation....
The filter 530DF28 for the Molecular Imager FX is a band pass filter for ECL Plus, AttoPhos, SYBR Green, Alexa Fluor 488, FITC, Cy2, and Pro-Q Emerald dyes....
... Fluorescein In Situ Apoptosis Detection Kit ... the indirect TUNEL method, utilizing an ... a Fluorescein reporter molecule. It provides ... Results are analyzed using either flow ...
... 3000 system, 220-240 V, is used for nucleic ... vertical slab gel format. The system includes the ... of separating nucleic acids with single base-pair resolution ... (IPC and bonded inner glass plate, outer glass ...
Biology Products: